Nissim Mashiach
CIK 1357777 · President and COO · last filed 2026-03-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$109.7K
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$316.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYPH | Director | 168,750 | $0.65 | $109.7K | $0 | 2 | 2026-03-17 |
| CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Director | — | $1.56 | — | $0 | 14 | 2025-11-13 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | President and COO | 27,000 | — | — | -$316.5K | 4 | 2008-10-30 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-01-18 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.